drugset
drugset / Trial / NCT02754596

Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution

NCT02754596 ↗

Phase 2 Completed 154 enrolled Glaukos Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized trial comparing two elution doses of the Travoprost Intraocular implant to timolol ophthalmic solution.

Timeline

Start
2016-03-29
Primary completion
2017-08-01
Completion
2020-07-21

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Timolol Other / unclassified 0.5 % Other
Subject Travoprost Other / unclassified — Other

Indications

open-angle glaucoma